Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target

Amin, N. and Clark, C.C.T. and Taghizadeh, M. and Djafarnejad, S. (2020) Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target. Journal of Trace Elements in Medicine and Biology, 57.

[img] Text

Download (509kB)
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....


Background: To this day, empirical data suggests that zinc has important roles in matrix synthesis, bone turnover, and mineralization and its beneficial effects on bone could be mediated through different mechanisms. The influence of zinc on bone turnover could be facilitated via regulating RANKL/RANK/OPG pathway in bone tissue. Therefore, the aim of the study was to conduct a review to investigate the possible effect of the zinc mediated bone remodeling via RANKL/RANK/OPG pathway. Methods: A comprehensive systematic search was performed in MEDLINE/PubMed, Cochrane Library, SCOPUS, and Google Scholar to explore the studies investigating the effect of zinc as a bone remodeling factor via RANKL/RANK/OPG pathway regulation. Subsequently, the details of the pathway and the impact of zinc supplements on RANKL/RANK/OPG pathway regulation were discussed. Results: The pathway could play an important role in bone remodeling and any imbalance between RANKL/RANK/OPG components could lead to extreme bone resorption. Although the outcomes of some studies are equivocal, it is evident that zinc possesses protective properties against bone loss by regulating the RANKL/RANK/OPG pathway. There are several experiments where zinc supplementation resulted in upregulation of OPG expression or decreases RANKL level. However, the results of some studies oppose this. Conclusion: It is likely that sufficient zinc intake will elicit positive effects on bone health by RANKL/RANK/OPG regulation. Although the outcomes of a few studies are equivocal, it seems that zinc can exert the protective properties against bone loss by suppressing osteoclastogenesis via downregulation of RANKL/RANK. Additionally, there are several experiments where zinc supplementation resulted in upregulation of OPG expression. However, the results of limited studies oppose this. Therefore, aside from the positive role zinc possesses in preserving bone mass, further effects of zinc in RANKL/RANK/OPG system requires further animal/human studies. © 2019 Elsevier GmbH

Item Type: Article
Additional Information: cited By 0
Uncontrolled Keywords: osteoclast differentiation factor; osteoprotegerin; receptor activator of nuclear factor kappa B; zinc; zinc sulfate, bone mass; bone remodeling; clinical outcome; down regulation; drug effect; drug targeting; human; nonhuman; osteoclastogenesis; osteolysis; priority journal; protein expression; protein function; regulatory mechanism; Review; supplementation; upregulation; zinc deficiency
Subjects: Biochemistry, Genetics and Molecular Biology
Divisions: Faculty of Medicine > Basic Sciences > Department of Biochemistry
Depositing User: ART . editor
Date Deposited: 05 Jan 2020 11:57
Last Modified: 05 Jan 2020 11:57
URI: http://eprints.kaums.ac.ir/id/eprint/4370

Actions (login required)

View Item View Item